Publications by authors named "Koki Fujii"

Claim this Profile
O
Olaparib-induced interstitial lung disease: A case series analysis.
Mototaka Hattori, Yu Mikami, Midori Sato, Hiroyuki Nagai, Koki Fujii

Respir Investig· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of comprehensive genomic profiling in non-small cell lung cancer: An analysis of a nation-wide database.
Koki Fujii, Michiko Ueki, Momoko Morishita, Hiroaki Ikushima, Hideaki Isago

Lung Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Adenocarcinoma Size Decrease after SARS-CoV-2 Vaccination during Long-Term Pembrolizumab Treatment: A Case Report.
Koki Fujii, Kensuke Fukuda, Masanori Kawakami, Akihisa Mitani, Goh Tanaka

Case Rep Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of alcohol intake and female gender with high expression of TMPRSS2 in tongue as potential risk for SARS-CoV-2 infection.
Kotaro Sato, Koki Fujii, Noriyuki Yamamoto, Norihisa Ichimura, Satoshi Yamaguchi

J Clin Biochem Nutr· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia.
Koki Fujii, Hideyuki Takeshima, Taku Nishimura, Toshio Sakatani, Yoshio Masuda

Respir Med Case Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Koki Fujii, Hidenori Takahashi, Nami Hayakawa, Yoshinobu Iwasaki

Respirol Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Koki Fujii, Hidenori Takahashi, Nami Hayakawa, Yoshinobu Iwasaki

Respirol Case Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis